NVS Novartis AG

  1. Stocks
  2. Healthcare
  3. NYSE: NVS

Price (delayed)

$110.32

Market cap

$225.1B

P/E Ratio

13.96

Dividend/share

$3.78

EPS

$7.9

Enterprise value

$246.18B

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world ...

Highlights
The company's EPS has surged by 118% YoY and by 7% QoQ
The company's net income has surged by 111% YoY and by 6% QoQ
The company's equity fell by 20% YoY but it rose by 5% QoQ
The quick ratio is down by 6% year-on-year
The company's debt rose by 6% QoQ and by 2.3% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.novartis.com/
Peers: PFE MRK JNJ TEVA

Key stats

What are the main financial stats of NVS
Market
Shares outstanding
2.04B
Market cap
$225.1B
Enterprise value
$246.18B
Valuations
Price to earnings (P/E)
13.96
Price to book (P/B)
5.39
Price to sales (P/S)
4.59
EV/EBIT
13.76
EV/EBITDA
9.03
EV/Sales
5.04
Earnings
Revenue
$48.86B
EBIT
$17.9B
EBITDA
$27.27B
Free cash flow
$14.29B
Per share
EPS
$7.9
Free cash flow per share
$7.03
Book value per share
$20.45
Revenue per share
$24.03
TBVPS
$21.89
Balance sheet
Total assets
$97.51B
Total liabilities
$55.6B
Debt
$28.99B
Equity
$41.73B
Working capital
-$1.92B
Liquidity
Debt to equity
0.69
Current ratio
0.93
Quick ratio
0.6
Net debt/EBITDA
0.77
Margins
EBITDA margin
55.8%
Gross margin
74.6%
Net margin
33.1%
Operating margin
24%
Efficiency
Return on assets
16%
Return on equity
38.9%
Return on invested capital
53%
Return on capital employed
25.6%
Return on sales
36.6%
Dividend
Dividend yield
3.42%
DPS
$3.78
Payout ratio
47.8%

NVS stock price

How has the Novartis AG stock price performed over time
Intraday
0.35%
1 week
3.95%
1 month
3.04%
1 year
6.19%
YTD
9.26%
QTD
3.63%

Financial performance

How have Novartis AG's revenue and profit performed over time
Revenue
$48.86B
Gross profit
$36.45B
Operating income
$11.73B
Net income
$16.18B
Gross margin
74.6%
Net margin
33.1%
The company's net income has surged by 111% YoY and by 6% QoQ
The company's net margin has surged by 92% YoY and by 3.8% QoQ
NVS's operating income is up by 30% year-on-year and by 11% since the previous quarter
NVS's operating margin is up by 19% year-on-year and by 9% since the previous quarter

Growth

What is Novartis AG's growth rate over time

Valuation

What is Novartis AG stock price valuation
NVS P/E details
P/E
13.96
P/B
5.39
P/S
4.59
EV/EBIT
13.76
EV/EBITDA
9.03
EV/Sales
5.04
The company's EPS has surged by 118% YoY and by 7% QoQ
The stock's P/E is 28% less than its 5-year quarterly average of 19.2 and 18% less than its last 4 quarters average of 17.0
NVS's P/B is 41% above its 5-year quarterly average of 3.8 and 7% above its last 4 quarters average of 5.0
The company's equity fell by 20% YoY but it rose by 5% QoQ
Novartis AG's revenue has increased by 10% YoY and by 2.4% QoQ
The P/S is 9% more than the 5-year quarterly average of 4.2 and 3.9% more than the last 4 quarters average of 4.4

Efficiency

How efficient is Novartis AG business performance
NVS's ROE has soared by 184% YoY and by 12% QoQ
Novartis AG's ROA has soared by 139% YoY and by 10% from the previous quarter
The ROIC has soared by 139% year-on-year and by 8% since the previous quarter
The company's return on sales has surged by 67% YoY and by 4.3% QoQ

Dividends

What is NVS's dividend history
Dividend details
DPS
$3.78
Dividend yield
3.42%
Payout ratio
47.8%
Recent dividends

Financial health

How did Novartis AG financials performed over time
NVS's total assets is 75% greater than its total liabilities
NVS's total assets is down by 12% year-on-year but it is up by 3.4% since the previous quarter
Novartis AG's current ratio has decreased by 11% YoY but it has increased by 3.3% QoQ
The company's debt is 31% lower than its equity
The debt to equity has grown by 25% YoY
The company's equity fell by 20% YoY but it rose by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.